Shares in Harvard Bioscience climbed 19 percent for the five-day trading period ended Tuesday, leading all gainers in the BCW Index. The company is in the midst of seeking a buyer for its capital equipment business. The only other firm to eclipse 5 percent growth for the tracking period was Invitrogen, whose shares rose 5.3 percent. Stratagene led decliners with a 2.8 percent drop.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.